Tuesday June 17 8:04 AM EDT
Company Press Release
ImmuDyne, Inc. Reports Complaint by Carmel Research,
Inc.
HOUSTON--(BW HealthWire)--June 17, 1997--ImmuDyne, Inc. (IMMD), announces that
Carmel Research, Inc. has filed a complaint against ImmuDyne in United States District Court,
District of Nevada, CV-N-97-00332-ECR, styled Carmel Research, Inc., Plaintiff, v. ImmuDyne,
Inc., Defendant alleging that ImmuDyne is infringing on two patents related to beta glucan
technology. Based solely on information provided by Carmel, the Nevada court issued a
Temporary Restraining Order (``TRO'') requiring that ImmuDyne stop selling MacroForce(tm)
dietary supplement products that contain beta glucan. The judge dissolved the TRO upon
consideration of information submitted by ImmuDyne. ImmuDyne is again selling its
MacroForce(tm) products.
A hearing has been set in Nevada United States District Court for June 19 to determine if a
temporary injunction will be ordered preventing ImmuDyne from selling MacroForce(tm) dietary
supplement products that contain beta glucan. Management of ImmuDyne does not believe the
allegations have merit and intends to vigorously defend against the allegations.
Management of ImmuDyne believes that the allegations by the plaintiffs in the Nevada litigation
have been resolved in the Summary Judgment Order entered in the 225th Judicial District Court,
Bexar County, Texas, in the case styled Mark McLaughlin and Tom McCarvill v. ImmuDyne, Inc.,
Byron A. Donzis, James D. Wood and Carmel Research, Inc., Cause No. 94-CI-035664. Please
refer to the April 8, 1997 press release of ImmuDyne regarding these settlement agreements.
Management of ImmuDyne believes that Carmel is instituting litigation in Nevada for the purpose of
a collateral challenge to the Summary Judgment Order. ImmuDyne intends to pursue enforcement
of the Summary Judgment Order at a hearing in the San Antonio court to be held Wednesday,
June 18 at 9:00 a.m.
ImmuDyne, Inc. is traded on the NASD Automated Bulletin Board under the symbol IMMD.
ImmuDyne, Inc. is a Texas-based biotechnology company specializing in macrophage technology.
It has proprietary technology relating to immune system stimulants for cosmetic, human nutritional,
animal nutritional and aquacultural use. ImmuDyne, Inc., maintains offices in Houston, Texas and
Palo Alto, California. For more information on the Company, contact Margaret Dreyfus, (415)
949-3864, or visit our website at www.immudyne.com .
Contact:
ImmuDyne, Inc.
Margaret Dreyfus, 415/949-3864
More news for referenced ticker symbols: IMMD, and related industries: biotechnology.
Help
Copyright c 1997 Business Wire. All rights reserved. All the news releases provided by Business Wire are
copyrighted. Any forms of copying other than an individual user's personal reference without express written
permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited
to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed
form.
Important Disclaimers and Legal Information
Questions or Comments
Sorry for buttin' in but I thought you might want to see it. I hold no position but have friends that are invested. |
